4-butyrolactone has been researched along with piplartine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcanjo, DDR; Campelo, YDM; de Moraes, J; de Souza de Almeida Leite, JR; Eaton, P; Guimarães, MA; Kato, MJ; Lima, DF; Mafud, AC; Mascarenhas, YP; Mendonça, RZ; Pinto, PLS; Silva, MPN; Véras, LMC; Yamaguchi, LF | 1 |
1 other study(ies) available for 4-butyrolactone and piplartine
| Article | Year |
|---|---|
Synergistic effects of in vitro combinations of piplartine, epiisopiloturine and praziquantel against Schistosoma mansoni.
Topics: 4-Butyrolactone; Animals; Antiprotozoal Agents; Cell Shape; Chlorocebus aethiops; Cricetinae; Dogs; Drug Synergism; Drug Therapy, Combination; Imidazoles; Madin Darby Canine Kidney Cells; Male; Mice; Microscopy, Confocal; Piperidones; Praziquantel; Schistosoma mansoni; Vero Cells | 2017 |